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Abstract
Although indolone-N-oxide (INODs) genereting long-lived radicals possess antiplasmodial
activity in the low-nanomolar range, little is known about their mechanism of action. To explore
the molecular basis of INOD activity, we screened for changes in INOD-treated malaria-infected
erythrocytes (Pf-RBCs) using a proteomics approach. At early parasite maturation stages,
treatment with INODs at their IC50 concentrations induced a marked tyrosine phosphorylation of
the erythrocyte membrane protein band 3, whereas no effect was observed in control RBCs. After
INOD treatment of Pf-RBCs we also observed: (i) accelerated formation of membrane aggregates
containing hyperphosphorylated band 3, Syk kinase, and denatured hemoglobin; (ii) dose-
dependent release of microvesicles containing the membrane aggregates; (iii) reduction in band 3
phosphorylation, Pf-RBC vesiculation, and antimalarial effect of INODs upon addition of Syk
kinase inhibitors; and (iv) correlation between the IC50 and the INOD concentrations required to
induce band 3 phosphorylation and vesiculation. Together with previous data demonstrating that
tyrosine phosphorylation of oxidized band 3 promotes its dissociation from the cytoskeleton, these
results suggest that INODs cause a profound destabilization of the Pf-RBC membrane through a
mechanism apparently triggered by the activation of a redox signaling pathway rather than direct
oxidative damage.
© 2011 Elsevier Inc. All rights reserved.
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Because of the emergence of drug-resistant strains of Plasmodium falciparum, the incidence
of malaria is increasing in many parts of the world. Although combinatorial therapies
involving artemisinin offer a first line of treatment for uncomplicated P. falciparum
infections, localized episodes of partial resistance are now emerging [1], emphasizing the
need for new antimalarial drugs.
We recently developed a series of new antiplasmodial compounds generating stable radical
species, 3-oxo-3H-indole-1-oxides (INODs)2, that display antiplasmodial activities in both
murine models of P. berghei infection and human cell culture models of P. falciparum
parasitemia. Because INODs have been shown to act at nanomolar concentrations and to
cause little toxicity [2], they have been proposed as promising candidates for future clinical
trials.
Unfortunately, little is known regarding the mechanism of action of INODs. Bunney and
Hooper [54] have noted that INODs exhibit redox potentials and generate long-lived free
radicals comparable to those of 1,4-quinones, suggesting that their biological activities may
be related to their abilities to create an oxidizing environment within the parasitized cell.
Indeed, the pharmacophore (i.e., the conjugated system between the nitrone and the ketone
functions that is essential for antimalarial activity) contains all of the oxidative properties of
this family of antimalarial drugs [2]. The fact that mutant erythrocytes that display a natural
resistance to P. falciparum (e.g., cells with glucose-6-phosphate dehydrogenase deficiency,
sickle cell anemia, or β-thalassemia) share a common predisposition to oxidative stress adds
strength to the conjecture that oxidative overload may contribute to INODs’ antimalarial
activity [3–6]. Not surprisingly, artemisinin, the most common antimalarial drug in use
today, is also distinguished by its redox activities and ability to induce an oxidative stress in
its target cell [2]. For unknown reasons the parasite itself triggers significant oxidative stress
during the infection process.
Intraerythrocyte P. falciparum cell cycle is characterized by a 48-h development. Merozoites
invade circulating erythrocytes and, within 12–24 h, the cytoplasm expands (ring forms) and
further matures to the trophozoite stage. At late stages of maturation the parasite undergoes
cellular segmentation and differentiation to form roughly 16–18 merozoite cells. At the end
of the cycle, the erythrocyte membrane is rapidly destroyed and merozoites burst from the
red blood cell to infect other erythrocytes. Soon after parasite invasion, a rapid decrease in
intracellular reduced glutathione and concomitant rise in oxidative damage to the host cell
are observed [3–5,7–12]. The prominent formation of denatured hemoglobin products, their
binding to the membrane, the oxidation and clustering of band 3 [8,10], and the peroxidation
of membrane lipids [13] provide further evidence for a parasite-induced oxidative milieu.
The membrane damage appears magnified in mutant erythrocytes [3–6]; therefore an
inadequate adaptive response of the host cells to the oxidative stress exerted by the
intracellular parasite seems to play a central role in the mechanism of protection conferred
by various mutations. In this already stressed condition, it can be hypothesized that any
additional oxidative stress imposed by INOD drugs could force an oxidative overload that is
simply too intense for the host–parasite system to survive.
We and others have noted that oxidative environments of the sort described above can
stimulate tyrosine phosphorylation of band 3, i.e., the major integral protein of the
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erythrocyte membrane. This increase in band 3 tyrosine phosphorylation, which derives
from both an oxidative activation of Syk kinase [14–16] and an oxidative inhibition of a
major tyrosine phosphatase [17], leads to significant changes in membrane properties,
altering both rates of glucose metabolism and multiple membrane protein interactions [18–
20]. We recently demonstrated that band 3 tyrosine phosphorylation may have a role in the
regulation of the structural stability of the red cell membrane causing the transition of band 3
molecules from a state of restricted lateral mobility to a state characterized by large mobility
through the plane of the membrane. In accordance with this result we observed that
phosphorylated band 3 greatly decreases its affinity to ankyrin, inducing membrane blebbing
and vesiculation [21]. The fact that similar phosphorylation of band 3 and membrane
destabilization are observed in G6PD-deficient erythrocytes that exhibit resistance to
parasite habitation [22] raises the question whether redox activation of band 3
phosphorylation and its biological sequelae might play a role in INOD suppression of
parasitemia.
In this paper, we conduct a comprehensive analysis of the host–parasite system’s oxidative
and phosphorylation changes that occur during P. falciparum red blood cell (Pf-RBC)
invasion in the presence and absence of INODs; INOD-1 was one of the most effective
compounds of the INOD series in inducing band 3 hyperphosphorylation. Using a
proteomics approach, we demonstrate that band 3 tyrosine phosphorylation constitutes the
most prominent change in Pf-RBC after INOD exposure at nanomolar concentrations. We
then offer a mechanism whereby this activity can provide a plausible pathway for INOD-
mediated suppression of parasitemia.
Experimental procedures
Unless otherwise stated, all materials were obtained from Sigma–Aldrich (St. Louis, MO,
USA).
Cultivation and preparation of P. falciparum-RBC membranes
Freshly drawn blood (Rh+) from healthy adults of both sexes was used after informed
consent in all studies. Blood anticoagulated with heparin was stored in citrate–phosphate–
dextrose with adenine before its use. RBCs were separated from plasma and leukocytes by
three washes in wash medium (RPMI 1640 medium containing 2 mM glutamine, 24 mM
NaHCO3, 25 mM Hepes, 20 mM glucose, and 32 mg/ml gentamicin, pH 6.80). P.
falciparum strain Palo Alto (mycoplasma free) was cultured at a hematocrit of 0.5% and
synchronized as previously described [23]. P. falciparum-infected cells were studied at
defined parasite maturation stages, i.e., 14 to 18 h (ring stage) or 34 to 38 h (trophozoite
stage). To assess total parasitemia and the relative numbers of ring- and trophozoite-stage
cells, slides were prepared from cultures at the indicated times and stained with Diff-Quik
stain before analysis of 400 to 1000 cells by microscopy. The parasitemia of cell populations
used in this study was routinely 25–40%. Standard hypotonic membranes were prepared at 4
°C on ice as follows: 150 μl of packed RBCs was diluted into 1.5 ml of cold hemolysis
buffer (5 mmol/L sodium phosphate, 1 mmol/L EDTA, pH 8.0) containing a protease and
phosphatase inhibitor cocktail (Sigma–Aldrich) and then washed up to four more times in
the same buffer in a refrigerated Eppendorf microfuge at 25,000 g. The preparations were
stored frozen at −80 °C until use. Membrane protein content was quantified using the DC
Protein Assay (Bio-Rad, Hercules, CA, USA).
Treatment of RBCs
RBCs and Pf-RBCs were washed 3× in phosphate-buffered saline (137 mM NaCl, 2.7 mM
KCl, 8.1 mM K2HPO4, 1.5 mM KH2PO4, pH 7.4) in the presence of 5 mM glucose (PBS-
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glucose) to obtain packed RBCs. RBCs were then resuspended at 30% hematocrit in PBS-
glucose and incubated at 37 °C in the presence and absence of various concentrations of
INOD-1 and for various incubation times. When necessary for kinase inhibitor studies,
infected and uninfected RBCs were treated with 10 μM Syk inhibitors II and IV
(Calbiochem) for 1 h at 37 °C in the dark.
Assay for denatured hemoglobin products
Denatured hemoglobin products were quantified by measuring heme absorbance at 560, 577,
and 630 nm [55] and expressed as nmol/ml of solubilized membranes.
Assay for GSH
GSH estimations were performed using 5,5′-dithiobis-(2-nitro-benzoic acid) [16].
Microvesicle isolation
Control RBCs, 20-h mature ring-stage RBCs, and 32-h mature trophozoite-stage RBCs were
washed 3× in RPMI 1640–Hepes medium and then resuspended at 10% hematocrit in the
same medium containing a protease inhibitor cocktail (Sigma–Aldrich). Cells were then
treated for the desired times with various concentrations of INODs, after which the samples
were pelleted at 800 g for 10 min at room temperature. Cell pellets were immediately used
to prepare membranes. Supernatants were collected and centrifuged at 25,000 g for 10 min
at 4 °C to eliminate spontaneously formed red cell ghosts. Supernatants, after the addition of
phosphatase inhibitors, were centrifuged for 3 h at 100,000 g in a refrigerated ultracentrifuge
(Beckman) to isolate microvesicles.
FACS analysis
Packed cells were resuspended at a 30% hematocrit in 2 mM PBS-glucose, treated with the
desired concentration of INOD-1, and incubated for 2.5 h at 37 °C under gentle shaking. Ten
microliters of RBC suspension was diluted 1:200 in PBS-glucose for FACS analysis. RBC
vesicles were quantified using a FACSCalibur cytometer (BD Biosciences) and analyzed
with CellQuest software (BD Biosciences). Vesicles were selected by forward and side light
scatter (FSC and SSC signals set to logarithmic amplification) and a total of ~40,000 events
were analyzed.
One-dimensional (1-DE) and two-dimensional electrophoresis (2-DE)
To perform 1-DE and 2-DE, RBC or Pf-RBC membrane proteins were solubilized and
separated as described [24].
Immunoblot analysis and Infrared fluorescence detection
Proteins obtained from 1-DE or 2-DE were transferred onto nitro-cellulose membranes and
further stained with either fluorescein-5′-maleimide (0.25 mg/ml; Pierce, Rockford, IL,
USA) or anti-phosphotyrosine antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
and anti-Syk (Santa Cruz) antibodies and with anti-band 3 (Sigma–Aldrich) and then
detected using an 800-nm laser scanner (Odyssey, Li-Cor, USA) as described [24]. To
ascertain the specificity of anti-phosphotyrosine staining, proteins were dephosphorylated
before gel electrophoresis by incubating the samples for 20 min at 30 °C with 6 μl (400
units) λ phosphatase in 50 mM Tris buffer, pH 7.5, 0.1 mM Na2EDTA, 5 mM dithiothreitol,
and 2 mM MnCl2.
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Gel staining and image analysis
Proteins separated by one-dimensional SDS–PAGE were stained with blue colloidal
Coomassie, and proteins separated on two-dimensional gels were stained with a mass
spectrometry-compatible silver stain. 2-DE Western blot images were digitized with a
GS800 scanner (Bio-Rad) and matched with corresponding stained gels using PDQuest
software (Bio-Rad).
Membrane proteins separated on Sepharose CL-6B
RBCs and Pf-RBCs were treated in the presence or absence of 300 nM INOD-1, and
membranes were prepared and fractionated as previously described [25].
Preparation of cells for immunofluorescence
Infected and uninfected RBCs were pelleted and rinsed twice in PBS, pH 7.4, containing 5
mM glucose and then fixed for 5 min in 0.5% acrolein in PBS. Fixed cells were fixed and
permeabilized as previously described [21]. Staining was performed using a rabbit anti-band
3 antibody (raised against purified recombinant cdb3) diluted in blocking buffer. Cells were
incubated with primary antibody for 45 min with motion and rinsed three times in blocking
buffer. Band 3 was visualized with Cy3-conjugated anti-rabbit antibody (Jackson
ImmunoResearch, West Grove, PA, USA) diluted in blocking buffer for 45 min and rinsed
twice in blocking buffer and then once in plain PBS. Cells were resuspended in Syto 16
nuclear acid stain (Invitrogen) diluted to 500 nM in PBS. Cells were incubated in the
counter-stain for 20 min with motion and then rinsed three times before observation. After
being labeled the RBCs were allowed to attach to coverslips coated with poly-L-lysine,
which were then mounted onto glass slides using Aqua-Mount (Lerner Laboratories, New
Haven, CT, USA). Samples were imaged in sequential mode to avoid bleed over with an
Olympus FluoView FV1000 (Tokyo, Japan) confocal microscope equipped with a 60×1.4
numerical aperture oil immersion lens. For easy visualization of color, the stains were
computer-assigned blue for DNA and green for band 3 using the Olympus FV10-ASW
software.
Peptide preparation for MS analysis
Bands and spots were excised from 1-DE and 2-DE gels, respectively, and proteins were
digested with trypsin. Bands and spots were processed as described [16].
Peptide mass fingerprinting by MALDI-TOF MS
Samples were loaded onto MALDI target using 1 μl of tryptic digest mixed 1:1 with a
solution of α-cyano-4-hydroxycinnamic acid (10 mg/ml in ACN/trifluoroacetic acid 0.1%,
40/60). MS analysis of peptides from 2-DE gel spots was performed as described [16].
Results
Analysis of INOD effects on proteomics of the host–parasite system
To perform a comprehensive study of the protein changes induced by INODs in Pf-RBC, we
treated control and ring- and trophozoite-stage RBCs with 100 nM INOD-1, i.e., a
representative INOD derivative (IC50 ~75 nM) chosen to represent this class of molecules
[2]. We chose 100 nM INOD-1 concentration to obtain a better resolution of the 2-DE
protein separations; at higher concentrations INOD-1 caused some smearing and proteolysis
possibly due to exceeding parasite toxicity. Membranes were prepared by hypotonic lysis
and extracted proteins were separated by 2-DE. A semiquantitative measure of the
abundance of each protein was then obtained by silver nitrate staining (Figs. 1A and D), and
the degree to which each polypeptide was altered by oxidation or phosphorylation was
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assessed by staining with fluorescein-5-maleimide (Figs. 1B and E), anti-phosphotyrosine
(Figs. 1C and F), or anti-phosphoserine antibodies (data not shown). As seen by comparison
of Figs. 1C and F (spot 3), INOD-1 induces a significant elevation of tyrosine
phosphorylation of band 3 in ring-infected RBCs, constituting the only statistically
significant INOD-induced change detected in these Pf-RBCs (p<0.01). To substantiate that
band 3 tyrosine hyperphosphorylation is the only significant variation, Fig. 2 shows the
levels of protein phosphorylation corresponding to Fig. 1. The protein spots numbered in
Fig. 1 and identified by mass spectrometry are listed in Table 1. In contrast, INOD-1 did not
impose any measurable changes in phosphorylation of uninfected or trophozoite-infected
RBCs (data not shown), nor did it induce any significant changes in gels stained with anti-
phosphoserine antibodies and fluorescein maleimide or silver nitrate. To add evidence to the
lack of overall oxidant effect (protein thiol oxidation) of low INOD-1 concentrations, we
measured GSH and GSSG levels after INOD-1 treatment without observing any significant
change (data not shown).
Characterization of INOD-induced changes in band 3 tyrosine phosphorylation
To enable better quantitation of band 3 tyrosine phosphorylation, we also examined INOD-
induced changes in tyrosine phosphorylation by SDS–PAGE followed by anti-
phosphotyrosine Western blotting. As shown in Fig. 3A, INOD-1 promoted a significant
increase (p<0.01) in ring-stage band 3 tyrosine phosphorylation (compare lanes 3 and 4), but
no significant change in uninfected (lanes 1 and 2) or trophozoite-stage Pf-RBC
phosphorylation (lanes 5 and 6).
At the schizont stage, we observed an extensive protein dephosphorylation (data not shown)
and a large variability between different parasite preparations. Dephosphorylation and the
variability in the patterns observed at schizont stage may be due to the combined effects of
variable degrees of proteolysis [26] and to the energetic decay that characterizes the terminal
parasite stages [27] (data not shown).
To study the involvement of Syk tyrosine kinase in INOD-1-induced band 3
phosphorylation, we pretreated the Pf-RBCs with Syk kinase inhibitors and examined the
effect of INOD-1 on band 3 tyrosine phosphorylation. Fig. 3A, lanes 7 and 8 show that
inhibition of Syk markedly decreases both basal and INOD-induced band 3 tyrosine
phosphorylation, in both ring- and trophozoite-stage Pf-RBCs (p<0.01).
Anti-band 3 Western blotting has previously shown that band 3 is somewhat depleted in
trophozoite-stage Pf-RBCs compared to ring stage and control cells from the same donor
[8,24]. More detailed analysis of the gels in Fig. 3B now suggests that INOD-1 treatment
further enhances depletion of band 3, in both ring- and trophozoite-stage Pf-RBCs (lanes 3,
4 and 5, 6). Moreover, Syk inhibitors can be seen to suppress the INOD-1-induced band 3
depletion, suggesting that band 3 depletion is influenced by its level of tyrosine
phosphorylation (Fig. 3B, lanes 7 and 8).
To further characterize the band 3 phosphorylation process, we mapped the sites of tyrosine
phosphorylation by mass spectrometry. This analysis revealed tyrosines 8 and 21 (Fig. 3C)
and 359 (Fig. 3D) as the major sites of phosphorylation. Consistent with the inhibition data,
phosphorylation of these residues has already been ascribed to the activity of Syk (Tyr 8 and
21) and possibly Lyn (Tyr 359) tyrosine kinases [15].
Activation of Syk kinase frequently involves its own tyrosine phosphorylation and
translocation to the membrane[15,16,28]. Therefore, to further explore the involvement of
Syk kinase in mediating the effects of INOD treatment in Pf-RBCs, we investigated its
phosphorylation along with its translocation to the membrane in response to INOD
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exposure. Fig. 3E shows that Syk gradually accumulates on the Pf-RBC membrane during
parasite maturation (compare lanes 1, 2, and 3) and that INOD-1 addition enhances this
accumulation (Fig. 3E, lanes 4, 5, and 6). Moreover, as seen in Fig. 3F, Syk phosphorylation
increases in proportion to its accumulation on the membrane, suggesting that the active
phosphorylated form of Syk translocates to the membrane. Although Lyn kinase often
cooperates with Syk in regulating various processes in hematopoietic cells, no evidence of
Lyn translocation to Pf-RBC membranes in either INOD-1-treated or untreated Pf-RBCs
could be detected using anti-Lyn antibodies and Western blots (data not shown).
Fig. 4 shows the concentration and time dependence of INOD-induced enhancement of band
3 tyrosine phosphorylation in ring-stage infected and control RBCs. Enhancement of
phosphorylation by 100 nM INOD-1 was clearly evident by 60 min of incubation and
phosphorylation progressively increased for the 6-h duration of the study. In control RBCs,
100 nM INOD-1 did not cause any measurable enhancement of band 3 tyrosine
phosphorylation, even after 6 h of exposure (Fig. 4A). The dose-dependent response to
INOD-1 revealed that, in ring-infected RBCs, enhanced tyrosine phosphorylation was
evident at 20 nM INOD-1, with maximal activity occurring at 300 nM concentration. In
control RBCs, a weak increase in band 3 tyrosine phosphorylation was measurable in the
300–500 nM INOD-1 concentration range, suggesting that very high doses of INOD-1 can
activate tyrosine phosphorylation even in uninfected erythrocytes (Fig. 4B).
To study the relationship between the antiplasmodial activity of INODs and their abilities to
induce band 3 tyrosine phosphorylation, we measured the parasite growth inhibition at
various INOD-1 concentrations. As shown in Fig. 4C INOD-1 exerts some antiplasmodial
activity in the low-nanomolar range (20 nM), which corresponds to the minimal
concentration required to trigger band 3 tyrosine phosphorylation. We do not have direct
evidence to explain the decrease in band 3 phosphorylation observed at 500 nM INOD-1
concentration. As this concentration is 6.6-fold higher than the IC50, we hypothesized that it
may result from a rapid antiplasmodial action and/or an effect on additional targets. To
further establish a causal relationship between INOD antiplasmodial activity and their ability
to induce band 3 phosphorylation we tested 66 different INOD compounds displaying
widely varying antiplasmodial activities in ring-infected RBCs [2]. Fig. 4D shows the
effects of these INODs after grouping them according to their IC50 values for inhibition of
parasitemia. In this figure, compounds with IC50 values below 100 nM (compounds 1, 11,
18, 22, 25, 44) were grouped together, as were compounds with IC50 values between 100
and 500 nM (compounds 9, 14, 17, 19, 23, 24, 48) and compounds with IC50 values greater
than 500 nM (compounds 5, 16, 60, 62, 43). INODs possessing IC50 values greater than 500
nM induced significantly (p<0.01) less band 3 tyrosine phosphorylation than INODs
possessing more potent antiplasmodial activity.
Characterization of the phosphorylated band 3 aggregates
As previously described [8], two major aggregation states of band 3 have been observed
during size-exclusion chromatography of detergent-extracted Pf-RBC membrane proteins: a
high-molecular-weight fraction (Fig. 5, fraction 1), corresponding to aggregates of band 3
and other proteins, and a lower-molecular-weight fraction (Fig. 5, fraction 2) consisting
mainly of band 3 dimers and tetramers. Importantly, INOD-1 (300 nM) treatment of ring-
infected RBCs caused a consistent increase in the higher-molecular-weight fraction. Thus,
whereas band 3 in uninfected RBCs is invariably found in the lower-molecular-weight
fraction (data not shown), a moderate proportion of the band 3 in ring-stage Pf-RBCs
segregated into this higher-molecular-weight fraction. Moreover, when these ring-stage Pf-
RBCs were treated with INOD-1, almost all of the band 3 shifted into this higher-molecular-
weight fraction (compare open and closed circles in Fig. 5A). That this fraction is heavily
oxidized can be seen from the facts that: (i) it contains a large amount of denatured
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hemoglobin products (open and closed squares),and (ii) it can be disaggregated by exposure
to dithiothreitol, a disulfide-reducing agent (Fig. 5B, fraction 1). Most significantly,
tyrosine-phosphorylated band 3 is seen only in this high-molecular-weight fraction (Fig. 5B,
fraction 2, compare lanes 1 and 2), suggesting that the phosphorylation event is somehow
linked to band 3 oxidation and aggregation. This hypothesis is, in fact, consistent with the
observation that INOD-1 exposure, which also enhances band 3 tyrosine phosphorylation
(Figs. 1C and F), similarly increases aggregate formation in Pf-RBCs (Fig. 5A).
Although an increase in the content of aggregated band 3 and associated denatured
hemoglobin products is also eventually seen in the untreated trophozoite-stage Pf-RBCs, no
additional effect of INOD-1 administration on either the composition or the quantity of these
aggregates could be detected (data not shown). Thus, the aforementioned effects of INOD-1
exposure can be induced prematurely in ring-stage Pf-RBCs, but later occur spontaneously
in trophozoite-stage Pf-RBCs.
Effect of INOD-1 on the release of microvesicles in infected RBCs
In Fig. 3B, we observed a decrease in the band 3 content of Pf-RBCs after INOD-1
treatment, suggesting that the band 3 population that is phosphorylated in response to
INODs can be lost from the membrane via release of microvesicles [29]. To test this
hypothesis, we isolated microvesicles from the supernatants of infected and uninfected
RBCs (hematocrit 25%) and measured their band 3 contents. Fig. 6A, lane 4, shows that
only a small amount of band 3 is isolated in the microvesicle fraction from untreated ring-
stage Pf-RBCs, whereas the major fraction of band 3 is found in the vesicular fraction of
trophozoite-stage Pf-RBCs (Fig. 6A, lane 7). Moreover, whereas exposure to 300 nM
INOD-1 induces only a small amount of vesiculation in uninfected RBCs (Fig. 6A, lanes 1
and 2), INOD-1 treatment causes dramatic vesiculation in ring-infected Pf-RBCs (Fig. 6A,
lanes 4 and 5; p<0.01). In trophozoite-stage cells, in contrast, the effect of INOD-1 addition
is not detectable, possibly because of the high level of vesiculation that occurs
spontaneously in these Pf-RBCs (Fig. 6A, lanes 7 and 8). Importantly, Syk kinase inhibitors
markedly reduced the extent of INOD-1-induced vesiculation in ring-infected RBCs (Fig.
6A, lanes 5 and 6), whereas the same inhibitors had no effect on trophozoite-stage RBCs
(Fig. 6A, lane 9).
Because the above data suggest a causal relationship between INOD exposure, band 3
tyrosine phosphorylation, and release of band 3-containing vesicles from ring-stage Pf-
RBCs, the linkage among these parameters was further examined. As seen in Fig. 6B, as
INOD-1 concentration is increased in ring-stage Pf-RBCs, release of band 3-containing
vesicles is also increased. Moreover, in Fig. 6C (lane 2), analysis of the released vesicles by
SDS–PAGE under nonreducing conditions reveals that all of band 3 is oxidatively cross-
linked, as confirmed by its shift to the expected molecular mass of ~100,000 Da upon
exposure to dithiothreitol (lane 5). Lanes 1 and 4 further reveal that band 3 in the vesicles is
heavily tyrosine phosphorylated and that the band 3 aggregate contains Syk, i.e., the kinase
responsible for this phosphorylation (lane 6). And as expected, spectrometric analysis of
solubilized vesicle proteins reveals the presence of large amounts of denatured hemoglobin
products (~2 nmol/mg protein; data not shown).
Finally, to provide visual evidence for the release of band 3-containing vesicles from Pf-
RBCs, ring- and trophozoite-stage Pf-RBCs were stained with an antibody to band 3 and
examined by confocal microscopy.
Fig. 7 shows immunofluorescence images of control ring and trophozoite infected red cells
treated with 300 nM INOD-1. Parasitized red cells often displayed surface membrane
protrusions containing band 3 that may constitute the source of the microvesicles released by
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Pf-RBC. Interestingly, the same protrusions were also present in untreated infected RBC
(data not shown). Because of exceeding differences between cell preparations and cell-to-
cell variations, we could not draw quantitative estimates of vesicle release.
The number of released vesicles could be readily quantified by flow cytometry, and as seen
in Fig. 7D, their abundance increased linearly with INOD-1 concentration. The results
shown in Fig. 6 were therefore now confirmed using a different methodology, although the
FACS analysis was apparently more sensitive at detecting vesiculation at low INOD-1
concentrations than Western blotting. In contrast, INOD-1 had no added effect on vesicle
release from trophozoite-infected RBCs, consistent with the constitutive high rate of vesicle
release from this stage of Pf-RBCs. Analysis of the released vesicles by electron microscopy
revealed large, electron-dense inclusions (Fig. 7E) that may represent the large membrane
aggregates detected in Figs. 5 and 6.
Antiplasmodial effect of INOD-1 at various P. falciparum maturation stages
Because the effects of INOD-1 on the molecular properties of Pf-RBCs were considerably
more pronounced during ring than during trophozoite stage, we asked whether INOD
inhibition of parasitemia might also be more prominent in ring-stage than in trophozoite-
stage cultures. For this purpose, synchronized parasite cultures at ring and trophozoite stages
were treated with 100 nM INOD-1 and then examined for parasite maturation. Treatment of
ring-infected Pf-RBCs resulted in 85% inhibition of parasite maturation (based on
trophozoite numbers 24 h after treatment with INOD-1 versus medium). In contrast,
treatment of trophozoite-infected Pf-RBCs resulted in only a 26% decline in the parasite
count after 24 h. These data support the involvement of the aforementioned INOD-
stimulated changes in ring-stage Pf-RBCs in the therapeutic mechanism of INOD-1. To
establish a causal relationship between INODs’ antiplas-modial effect and band 3
hyperphosphorylation we pretreated ring-infected Pf-RBCs with Syk inhibitors (10 μM)
before treatment with INOD-1 (100 nM). We found that Syk inhibition caused an ≈ 40%
decrease in INOD-1 antiplasmodial activity.
Discussion
Previous work has demonstrated the potent antimalarial activity of INODs in both parasite
cultures in vitro and murine models of P. berghei infection in vivo [2]. However, apart from
the essential role of their redox-active pharmacophore, little can be speculated about their
mechanism of action. Based on the data presented above, we wish to propose the following
hypothesis. We hypothesize that P. falciparum requires a stable erythrocyte membrane
during early stages of infection for successful parasite maturation. Oxidative stress, a
prominent consequence of parasite growth [8,24,30], leads directly to membrane
destabilization by: (i) dissociating ankyrin from band 3 via tyrosine phosphorylation of band
3 [21], (ii) weakening the spectrin–protein 4.1–actin junctional complex [31], and (iii)
promoting formation of hemichrome-enriched membrane protein aggregates [8]. This
membrane destabilization in turn results in membrane vesiculation and a decline in Pf-RBC
surface-to-volume ratio. INODs apparently enhance this membrane destabilization by
shifting Pf-RBCs, which are already oxidatively stressed [24], toward an even more intense
oxidative environment. Within this heightened oxidative milieu, infected erythrocytes
become not only less hospitable for parasite maturation, but also less mechanically stable
and capable of harboring the developing parasite.
The hypothesized requirement for a stable red cell membrane for completion of the
parasite’s life cycle is suggested by the observation that perturbations that compromise the
architecture of the membrane, including mutations in critical structural proteins [32–34],
defects in hemoglobin stability [35], and deficiencies in important metabolic enzymes [36],
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confer variable degrees of resistance to malaria or are protective against its more severe
complications. Indeed, erythrocytes with naturally unstable membranes (e.g., hereditary
spherocytosis, hereditary pyropoikilocytosis, hereditary elliptocytosis, Asian ovalocytosis)
do not support Plasmodium proliferation in vitro [32,37–40]. Furthermore, treatment of red
cells with morphology-altering drugs has been shown to inhibit entry and maturation of the
parasite in cell culture [41]. And most importantly, RESA, a parasite-encoded protein that is
critical for Plasmodium proliferation, functions by stabilizing the infected cell membrane
during early stages of parasite development; i.e., ring-infected RBCs devoid of RESA
undergo membrane vesiculation and loss of parasite viability early in the parasite’s life cycle
[42–44].
Data suggesting that oxidative overload creates an inhospitable environment for parasite
maturation include the facts that sickle cell disease [45], G6PD deficiency [4,46], α- and β-
thalassemias [47], and oxidizing drugs [2,48] all inhibit parasite growth. One might
therefore inquire how oxidative overload leads to suppression of parasitemia? Whereas an
oxidative milieu can be damaging to almost any protein, detailed studies have shown that
specific defects emerge in the red cell membrane in response to oxidation of membrane
sulfhydryls. In G6PD-deficient red cells we have recently demonstrated that persistent band
3 oxidation and phosphorylation cause progressive membrane vesiculation and release of
hemichromes [16,22]. Interestingly, we have observed that parasites growing in G6PD-
deficient red cells exert a marked oxidative effect at early stages of maturation and cause
increased vesiculation at this stage (R. Vono et al., unpublished results).
We have demonstrated that band 3 sulfhydryls are oxidatively cross-linked during early
stages of parasite maturation [8,30]. The formation of these disulfide bonds between
cysteine 201 of one subunit of band 3 and cysteine 317 of the other subunit has been further
shown to lead to loss of ankyrin affinity [49]. The resulting dissociation of ankyrin from
band 3 due to band 3 oxidation will be further aggravated by oxidation of sulfhydryls in Syk
and erythrocyte tyrosine phosphatases, both of which lead to enhancement of band 3
tyrosine phosphorylation [16] and ankyrin dissociation [21]. Oxidation of cysteines in
spectrin have also been shown to destabilize the spectrin–protein 4.1–actin junctional
complex [31]. Finally, oxidative overload can also promote hemichrome formation, resulting
in band 3 clustering, autologous antibody binding, complement deposition, and erythrocyte
phagocytosis by macrophages [8,16,30,50]. Not surprisingly, these hemichromes form at an
accelerated rate in thalassemic, sickle, and G6PD-deficient erythrocytes [6,8].
The sequelae of oxidative effects on membrane tyrosine phosphate content deserve more
detailed elaboration. As noted above, oxidative stress results in a dramatic rise in band 3
tyrosine phosphorylation, which, as shown recently by us [24], triggers complete
dissociation of ankyrin from band 3 [21]. Because rupture of the band 3–ankyrin bridge by
any mechanism is well documented to lead to membrane vesiculation [21], loss of
membrane surface area naturally follows elevation of band 3 tyrosine phosphorylation.
Consistent with this possible mechanism, band 3 tyrosine phosphorylation in ring-infected
RBCs was found to constitute the major covalent modification induced by INODs. Because
this process occurred over the same concentration range as INOD’s antiplasmodial activity,
we hypothesized that elevation of band 3 tyrosine phosphorylation and the consequent
weakening of membrane interactions play a critical role in the therapeutic action of INODs.
INODs showed higher antiplasmodial activity, more band 3 modifications, and membrane
vesiculation at the ring stage; this observation has been confirmed by a recent study
performed in Cameroon on fresh P. falciparum clinical isolates [51]. A major challenge of
the present work was then to establish a causal linkage between phosphorylation of band 3
induced by INODs, increased vesiculation of Pf-RBCs, and antiplasmodial activity.
Importantly, several observations were found to support this mechanistic linkage: (i) in ring-
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infected RBCs, INOD-1 triggered a dose-dependent increase in band 3 phosphorylation and
a parallel increase in vesicle release in a concentration range corresponding to its IC50; (ii)
Syk kinase inhibitors concomitantly suppressed band 3 phosphorylation, the release of
membrane vesicles, and antiplasmodial activity of INODs; (iii) the antiplasmodial activities
of a large series of INODs positively correlated with their capability to induce band 3
phosphorylation and vesiculation; (iv) INODs enhanced the phosphorylation of Syk kinase
and its consequent translocation to the membrane; (v) INOD treatment promoted the
formation of large protein complexes containing Syk kinase, denatured hemoglobin
products, and hyperphosphorylated and oxidatively cross-linked band 3; and (vi) vesicles
released from INOD-treated Pf-RBCs contained the same protein components seen in the
aforementioned high-molecular-weight complexes. Together with our data on oxidative
changes in INOD-treated Pf-RBCs, these observations indicate a causal relationship between
INOD antiplasmodial activity, band 3 tyrosine phosphorylation, and the consequent red cell
membrane destabilization. Together with our data on the selective phosphorylation of the
oxidized band 3 molecules [16], we suggest that, similar to other phosphorylation pathways
activated by redox signaling [52,53], in erythrocytes band 3 tyrosine phosphorylation may
result from the interaction between the oxidative stress exerted by the intracellular parasites
and specifically modified free radical compounds.
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Fig. 1.
Proteomics analysis of ring-infected RBCs after INOD-1 treatment. 2-DE maps of (A, B, C)
untreated ring-infected RBCs (Ring) and (D, E, F) ring-infected RBCs treated with 100 nM
INOD-1 (Ring+INOD-1) were prepared. 100 μg membrane protein was loaded and
separated by isoelectric focusing on a 3–10 IPG strip before further separation by 10%
SDS–PAGE. Gels were silver stained (A, D) or blotted onto nitrocellulose and then stained
with either fluorescein-5-maleimide (F5M; 0.25 mg/ml; B, E) or anti-phosphotyrosine
antibody (anti-pTyr; C, F). The arrows in (C) and (F) indicate band 3 protein. Images were
acquired by scanning densitometry (Image Master VDS; Pharmacia) (A, B, D, E) or
fluorescence detection (Odyssey IR; Li-Cor, USA) (C, F). Differential analysis of untreated
compared to treated cells was conducted using PD Quest (Bio-Rad). The proteins numbered
in (B), (C), (E), and (F) were identified by mass spectrometry (MALDI-TOF Micro MX;
Micromass, Manchester, UK) and are listed in Table 1.
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Fig. 2.
Quantification of protein phosphorylation levels of ring-infected RBC protein separated by
2-DE. Quantitative densitometry of protein phosphorylation levels corresponding to
phosphoproteins numbered in Figs. 1C and 1F was performed using a laser IR fluorescence
detector (Odyssey, Li-Cor) with Odyssey version 3.0 and expressed as arbitrary fluorescence
units. Results are averages±SD of three separate experiments.
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Fig. 3.
Analysis of band 3 phosphorylation and Syk translocation to the membrane induced by
INOD-1. 1-DE maps of membrane proteins were obtained by 8% SDS–PAGE of control
RBCs (C), ring-stage RBCs (R), and trophozoite-stage RBCs (T). Gels were analyzed by
Western blotting using (A) anti-phosphotyrosine (anti-pTyr) or (B) anti-band 3 antibodies.
Control RBCs and ring- and trophozoite-infected RBCs were treated with 100 nM INOD-1
(lanes 2, 4, 6) and with 100 nM INOD-1 in presence of 10 μM Syk inhibitors II and IV
(lanes 7, 8). Gel slices corresponding to the band 3 region were subjected to trypsin
digestion and analyzed by MALDI-TOF Micro MX (Micromass). The mass spectra revealed
band 3 tryptic peptides containing (C) Tyr 8 and 21, 6538 (unphosphorylated) and 6698 Da
(double phosphorylated), and (D) Tyr 359, 1760.9 (unphosphorylated) and 1840.9 Da
(phosphorylated). Intensity values are presented as the percentage of the highest intensity
ion. Membrane proteins were separated by 8% SDS–PAGE and analyzed by Western
blotting using (E) anti-Syk and (F) anti-pTyr antibodies. Infected RBCs were treated with
(lanes 4–6) or without 300 nM INOD-1 (lanes 1–3). Gels were run under reducing
conditions. Images were acquired using a laser IR fluorescence detector (Odyssey, Li-Cor).
Quantitative densitometry of band 3 phosphorylation level (A), band 3 content (B), Syk
content (E), and Syk phosphorylation level (F) was performed using a laser IR fluorescence
detector (Odyssey, Li-Cor) with Odyssey version 3.0 and expressed as arbitrary fluorescence
units. Results are averages±SD of five separate experiments.
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Fig. 4.
Effect of the antimalarial potency, concentration, and incubation time of INODs on band 3
tyrosine phosphorylation. Proteins were separated by 8% SDS–PAGE and analyzed by
Western blotting using an anti-phosphotyrosine (anti-pTyr) antibody. (A) Membrane
proteins of control RBCs (CTRL) and ring-infected RBCs (Ring) were treated with 100 nM
INOD-1 for various incubation times. (B) Control RBCs and ring-infected RBCs were
treated with various concentrations of INOD-1 for 3 h of incubation. Quantitative
densitometry of band 3 phosphorylation was performed using a laser IR fluorescence
detector (Odyssey, Li-Cor) with Odyssey version 3.0 software and expressed as arbitrary
fluorescence units. (C) Percentage of parasite growth inhibition induced by various INOD-1
concentrations at ring stage. (D) Average levels of band 3 tyrosine phosphorylation induced
by 64 different INODs are plotted as a function of the IC50 values of the INOD species. For
the purpose of simplification, INOD derivatives were grouped into three groups according to
their IC50 ranges: 0–100, 100–500, and >500 nM. Data were acquired as described for Figs.
4A and 4B. Results are averages±SD of three separate experiments.
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Fig. 5.
Analysis of the phosphorylation and aggregation states of band 3 complexes in ring-infected
RBCs±INOD-1 treatment. Proteins were extracted from membranes of ring-infected RBCs
by incubation in 1% Triton X-100 and separated by gel-filtration chromatography on 40×1-
cm Sepharose CL-6B. (A) Two fractions were obtained: Fraction 1 comprised higher-
molecular-weight components and Fraction 2 comprised lower-molecular-weight
components. Eosin maleimide-labeled band 3 fluorescence was measured in each fraction
and expressed as arbitrary units. Denatured hemoglobin (dHb) was quantified by visual
spectroscopy and expressed as nmol/ml. (B) Fractions 1 and 2 were analyzed by Western
blotting with anti-pTyr (lanes 1 and 4), anti-band 3 (Bd3) (lanes 2 and 5), and anti-Syk
(lanes 3 and 6) antibodies. Gels were run under nonreducing conditions. Images were
acquired using a laser IR fluorescence detector (Odyssey, Li-Cor).
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Fig. 6.
Effect of INOD-1 treatment on the release of microvesicles from control and infected RBCs.
Microvesicles were isolated from the supernatants of control (C) and ring (R) and
trophozoite (T) infected RBCs, separated by 8% SDS–PAGE, and analyzed by Western
blotting using anti-band 3 antibody. (A) Microvesicles released after 3 h treatment with 300
nM INOD-1 in the presence (lanes 3, 6, 9) or absence (lanes 1, 2, 4, 5, 7, 8) of 10 μM Syk
inhibitors II and IV. (B) Microvesicles released from control (CTRL) and ring-infected
(Ring) RBCs after treatment with increasing concentrations of INOD-1. (C) Microvesicles
isolated from ring-infected RBCs visualized with anti-band 3 (Bd3), anti-pTyr, or anti-Syk
antibodies under nonreducing and reducing conditions. Images were acquired using Odyssey
IR fluorescence detector (Li-Cor). Quantitative densitometry of band 3 (A, B) was
performed using a laser IR fluorescence detector (Odyssey; Li-Cor) with Odyssey version
3.0 software and expressed as arbitrary fluorescence units. Results are averages±SD of three
separate experiments.
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Fig. 7.
Confocal images of control and infected RBCs after INOD-1 treatment and analysis of
released vesicles. (A, B, C) Cells were pretreated with 300 nM INOD-1, isolated, and
stained with anti-band 3 antibody (green) and DAPI for DNA (blue). (D) Vesicles released
from control and infected RBCs, ring and trophozoite (Troph), after treatment with various
concentrations of INOD-1 were quantified by FACS (FACSCalibur cytometer; BD
Biosciences) using CellQuest software (BD Biosciences). The number of vesicles was
expressed as arbitrary units. Results are averages±SD of three separate experiments. (E) An
electron microscopy image of vesicles isolated from infected RBCs. Ultrathin sections were
stained with osmium tetraoxide, examined, and photographed using a Zeiss EM 900
transmission electron microscope (Carl Zeiss Jena GmbH, Jena, Germany), operating at 80
kV. Bar, 1 μm.
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